WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 14'4001 Infant (under 12 months) mortality rate: 252
GDP / capita (US$): 26'6471 Child (under 5 years) mortality rate: 282

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 1'337  1'333  1'328  1'323  1'316  1'268  1'222  1'085 
Births 20  20  20  20  20  19  25  31 
Surviving infants 19  19  20  20  20  18  25  30 
Pop. less than 5 years 97  98  97  97  96  90  133  132 
Pop. less than 15 years 277  276  275  275  276  324  410  369 
Female 15-49 years 359  363  366  369  370  353  314  282 

Number of reported case

(Click for retrospective incidence data for Trinidad and Tobago)
Diphtheria
Japanese encephalitis
Measles 511  384 
Mumps
Pertussis 10 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 10  28 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Trinidad and Tobago)
Vaccine year result method % card seen                                                
BCG         
DTP1 2004  86  MICS   78.8  87  89  89  95  91  90 
DTP3 2004  77  MICS   78.8  92  90  90  90  90  90  82  26 
HepB_BD         
HepB3 2004  74  MICS   78.8  92  90  90  90  90 
Hib3 2004  16  MICS   78.8  92  90  90  90  90  74 
JapEnc         
MCV 2004  91  MICS   78.8  85  92  92  94  91  90  71 
MCV2          85  99*  99*  80  81 
PCV1          81 
PCV3          39 
Pol3 2004  86  MICS   78.8  91  91  91  90  91  90  87  38 
Rota1         
Rota_last         
Rubella1          86  92  92  94  91 
TT2plus          14  14  14  16  15 
PAB         
VAD1         
YFV 2004  89  MICS   78.8  85  95  95  95  86 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Trinidad and Tobago)
DTP1 97  96  96  95  91  90  94  51 
DTP3 92  90  90  90  90  90  82  26 
HepB3 92  90  90  90  90 
Hib3 92  90  90  90  90  74 
MCV 85  92  92  94  91  90  70 
PCV3 39 
Pol3 91  91  91  90  91  90  87  38 
Rota_last
YFV 85  95  95  94  86  91 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 78
From 80 to 89% 22
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DT 2, 4, 6, 18, 60 months; Yes Children Allergic to Pertussis
DTwP 18, 60 months; Yes
DTwPHibHep 2, 4, 6 months; Yes
HIB 2, 4, 6 months; Yes
HPV No From January 2013
HepB > 10 years (x3 doses) Yes adolescents and adults
IPV 2, 4, 5, 18 months: 4-5 years; Yes HIV positive
Influenza 6 months; >3 years; Yes
MMR 12 months; 4 years; Yes
MenC_conj >=3 years; Yes
OPV 2, 4, 6, 18 months; 4-5 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Pneumo_ps >= 24 months; Yes Children and Adults
Td > = 7 years; Yes school leavers and adults
YF 1, 11 years; Yes and travellers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012 -2013  2011-2012  2010-2011  2009-2010  2008-2009  2007-2008  2006-2007 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No    No         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  89  89  100  89  78  78 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 33  56  56  67  44     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100    100  100      100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.